Track the 샤페론 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 샤페론 has recorded 32 reports. Market capitalisation: €24.6bn. The latest transaction was filed on 29 June 2026 (Other). Among the most active insiders: 유안타인베스트먼트. Every trade is openly available.
32
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
17 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 26,167 of 26,212 companies
2.8
score / 100
Value
4
Quality
2
FCF yld-59%
Earn yld-61%
EV/EBITDA·
ROE-92%
Gross mgn-41%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
샤페론 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for disease treatment.